Cullinan Therapeutics, Inc.

CGEM·NASDAQ·$15.46Share Price as of 11/2·$950MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/02/26 8-KCurrent report09/24/26 8-KCurrent report09/14/26 8-KCurrent report08/13/26 8-KCurrent report08/06/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration04/28/26 S-8Registration of securities for employees03/10/26 S-8Registration of securities for employees02/27/25 424B3Prospectus06/04/24 S-3Shelf registration05/16/24

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy05/16/24

Ownership

Form 4Insider transaction09/10/26 144Proposed sale of securities09/08/26 Form 4Insider transaction08/14/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/25/25 EFFECTRequest for effectiveness06/04/24 CORRESPCorrespondence with the SEC05/31/24 UPLOADLetter from the SEC05/20/24